FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Franz-Josef Schmitz

Research Profile

Procedures

Living Beings

Physiology

Chemicals & Drugs

Geographic Areas

Europe

Disorders

Objects

Hospitals, University

Co-author Network

Publications

TOP 3
R Geisel; S Geisel; Franz-Josef Schmitz; Birgit Henrich
[Modern diagnostics for urological infections].
Axel Dalhoff; Franz-Josef Schmitz
In vitro antibacterial activity and pharmacodynamics of new quinolones.
D Milatovic; Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Franz-Josef Schmitz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: R Geisel; S Geisel; Franz-Josef Schmitz; Birgit Henrich
[Modern diagnostics for urological infections].
Der Urologe. Ausg. A 2003;42(5):634-40.
2003: Axel Dalhoff; Franz-Josef Schmitz
In vitro antibacterial activity and pharmacodynamics of new quinolones.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003;22(4):203-21.
2003: D Milatovic; Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates.
Antimicrobial agents and chemotherapy 2003;47(1):400-4.
2002: Franz-Josef Schmitz; Paul Higgins; Susanne Mayer; Ad C Fluit; Axel Dalhoff
Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(9):647-59.
2002: Franz-Josef Schmitz; Andreas Beeck; Mirella Perdikouli; Mechthild Boos; Susanne Mayer; Sybille Scheuring; Karl Köhrer; Jan Verhoef; Ad C Fluit
Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.
Journal of clinical microbiology 2002;40(4):1546-8.
2002: Franz-Josef Schmitz; D Milatovic; Mechthild Boos; Susanne Mayer; Ad C Fluit
In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility.
The Journal of antimicrobial chemotherapy 2002;49(4):698-701.
2002: Franz-Josef Schmitz; Jasmina Petridou; Harold Jagusch; Nadine Astfalk; Sybille Scheuring; Stefan Schwarz
Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin.
The Journal of antimicrobial chemotherapy 2002;49(4):611-7.
2002: Franz-Josef Schmitz; Mechthild Boos; Susanne Mayer; Karl Köhrer; Sybille Scheuring; Ad C Fluit
In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones.
Antimicrobial agents and chemotherapy 2002;46(3):934-5.
2002: Matthias Steiert; Franz-Josef Schmitz
Dalbavancin (Biosearch Italia/Versicor).
Current opinion in investigational drugs (London, England : 2000) 2002;3(2):229-33.
2002: Franz-Josef Schmitz; Mechthild Boos; Susanne Mayer; Harold Jagusch; Ad C Fluit
Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2002;49(2):283-7.
2002: Franz-Josef Schmitz; Jasmina Petridou; Nadine Astfalk; Karl Köhrer; Sybille Scheuring; Stefan Schwarz
Molecular analysis of constitutively expressed erm(C) genes selected in vitro by incubation in the presence of the noninducers quinupristin, telithromycin, or ABT-773.
Microbial drug resistance (Larchmont, N.Y.) 2002;8(3):171-7.
2002: Franz-Josef Schmitz; Mechthild Boos; Susanne Mayer; Jan Verhoef; D Milatovic; Ad C Fluit
In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs.
The Journal of antimicrobial chemotherapy 2002;49(1):220-3.
2001: Franz-Josef Schmitz; Mirella Perdikouli; Andreas Beeck; Jan Verhoef; Ad C Fluit
Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates.
The Journal of antimicrobial chemotherapy 2001;48(6):935-6.
2001: Franz-Josef Schmitz; Jan Verhoef; D Milatovic; Ad C Fluit
Treatment options for Streptococcus pneumoniae strains resistant to macrolides, tetracycline, quinolones, or trimethoprim/sulfamethoxazole.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(11):827-9.
2001: Franz-Josef Schmitz; Mirella Perdikouli; Andreas Beeck; Jan Verhoef; Ad C Fluit
Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates.
International journal of antimicrobial agents 2001;18(5):433-6.
2001: R Geisel; Franz-Josef Schmitz; Ad C Fluit; H Labischinski
Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(10):685-97.
2001: Franz-Josef Schmitz; Mechthild Boos; Harold Jagusch; Susanne Mayer; Ad C Fluit; Dieter Hafner
Induction of in vitro resistance to BMS-284756 by Streptococcus pneumoniae.
The Journal of antimicrobial chemotherapy 2001;48(4):588-90.
2001: Franz-Josef Schmitz; Dieter Hafner; R Geisel; P Follmann; C Kirschke; Jan Verhoef; Karl Köhrer; Ad C Fluit
Increased prevalence of class I integrons in Escherichia coli, Klebsiella species, and Enterobacter species isolates over a 7-year period in a German university hospital.
Journal of clinical microbiology 2001;39(10):3724-6.
2001: Franz-Josef Schmitz; Mechthild Boos; Susanne Mayer; Dieter Hafner; Harold Jagusch; Jan Verhoef; Ad C Fluit
Propensity of fluoroquinolones with different moieties at position 8 to cause resistance development in clinical isolates of Streptococcus pneumoniae.
Antimicrobial agents and chemotherapy 2001;45(9):2666-7.
2001: Franz-Josef Schmitz; Mechthild Boos; Susanne Mayer; Jan Verhoef; D Milatovic; Ad C Fluit
In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae.
The Journal of antimicrobial chemotherapy 2001;48(1):148-52.
2001: Franz-Josef Schmitz; Jasmina Petridou; Nadine Astfalk; Sybille Scheuring; Karl Köhrer; Jan Verhoef; Ad C Fluit; Stefan Schwarz
Structural alterations in the translational attenuator of constitutively expressed erm(A) genes in Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2001;45(5):1603-4.
2001: Susanne Mayer; Mechthild Boos; Karl Köhrer; Ad C Fluit; Franz-Josef Schmitz
In vitro development of resistance to newer fluoroquinolones in Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(4):288-91.
2001: Franz-Josef Schmitz; A Fisher; Mechthild Boos; Susanne Mayer; D Milatovic; Ad C Fluit
Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(3):219-22.
2001: Mechthild Boos; Susanne Mayer; A Fischer; Karl Köhrer; Sybille Scheuring; P Heisig; Jan Verhoef; Ad C Fluit; Franz-Josef Schmitz
In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2001;45(3):938-42.
2001: Franz-Josef Schmitz; Ad C Fluit; Andreas Beeck; Mirella Perdikouli
Development of chromosomally encoded resistance mutations in small-colony variants of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2001;47(1):113-5.
2000: Franz-Josef Schmitz; Ad C Fluit; Dieter Hafner; Andreas Beeck; Mirella Perdikouli; Mechthild Boos; Sybille Scheuring; Jan Verhoef; Karl Köhrer; C Von Eiff
Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates.
Antimicrobial agents and chemotherapy 2000;44(11):3229-31.
2000: Sylvain Brisse; D Milatovic; Ad C Fluit; K Kusters; A Toelstra; Jan Verhoef; Franz-Josef Schmitz
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping.
Journal of clinical microbiology 2000;38(10):3636-45.
2000: Franz-Josef Schmitz; Ad C Fluit; E Lindenlauf; Sybille Scheuring; Karl Köhrer
Molecular analyses of possible mechanisms coding for low-level mupirocin resistance in clinical Staphylococcus aureus isolates.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(8):649-50.
2000: Franz-Josef Schmitz; Ad C Fluit; D Milatovic; Jan Verhoef; Hans-Peter Heinz; Sylvain Brisse
In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2000;46(1):109-13.
2000: Franz-Josef Schmitz; R Sadurski; A Kray; Mechthild Boos; R Geisel; Karl Köhrer; Jan Verhoef; Ad C Fluit
Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals.
The Journal of antimicrobial chemotherapy 2000;45(6):891-4.
2000: Franz-Josef Schmitz; J Petridou; Ad C Fluit; U Hadding; G Peters; C von Eiff
Distribution of macrolide-resistance genes in Staphylococcus aureus blood-culture isolates from fifteen German university hospitals. M.A.R.S. Study Group. Multicentre Study on Antibiotic Resistance in Staphylococci.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(5):385-7.
2000: Ad C Fluit; ME Jones; Franz-Josef Schmitz; J Acar; R Gupta; Jan Verhoef
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(3):454-60.
2000: M E Jones; N M Boenink; Jan Verhoef; Karl Köhrer; Franz-Josef Schmitz
Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment.
The Journal of antimicrobial chemotherapy 2000;45(3):353-6.
2000: Matthias Steiert; Franz-Josef Schmitz
PD-140248 (Parke-Davis & Co).
IDrugs : the investigational drugs journal 2000;3(2):223-7.
2000: M E Jones; D F Sahm; N Martin; Sybille Scheuring; P Heisig; C Thornsberry; Karl Köhrer; Franz-Josef Schmitz
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season.
Antimicrobial agents and chemotherapy 2000;44(2):462-6.
2000: Sylvain Brisse; D Milatovic; Ad C Fluit; Jan Verhoef; Franz-Josef Schmitz
Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(1):64-8.
1999: Franz-Josef Schmitz; Ad C Fluit; Sylvain Brisse; Jan Verhoef; Karl Köhrer; D Milatovic
Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates.
FEMS immunology and medical microbiology 1999;26(3-4):281-7.
1999: Sylvain Brisse; Ad C Fluit; U Wagner; P Heisig; D Milatovic; Jan Verhoef; Sybille Scheuring; Karl Köhrer; Franz-Josef Schmitz
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones.
Antimicrobial agents and chemotherapy 1999;43(10):2513-6.
1999: Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group.
International journal of antimicrobial agents 1999;12(4):311-7.
1999: Sylvain Brisse; D Milatovic; Ad C Fluit; Jan Verhoef; N Martin; Sybille Scheuring; Karl Köhrer; Franz-Josef Schmitz
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins.
Antimicrobial agents and chemotherapy 1999;43(8):2051-5.
1999: Franz-Josef Schmitz; A Krey; R Geisel; Jan Verhoef; Hans-Peter Heinz; Ad C Fluit
Susceptibility of 302 methicillin-resistant Staphylococcus aureus isolates from 20 European university hospitals to vancomycin and alternative antistaphylococcal compounds. SENTRY Participants Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(7):528-30.
1999: Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals. SENTRY Participants Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):450-3.
1999: Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):414-21.
1999: ME Jones; Franz-Josef Schmitz; Ad C Fluit; J Acar; R Gupta; Jan Verhoef
Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an International Surveillance Programme. SENTRY Participants Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):403-8.
1999: R Geisel; Franz-Josef Schmitz; L Thomas; G Berns; O Zetsche; B Ulrich; Ad C Fluit; H Labischinsky; Wolfgang Witte
Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area.
The Journal of antimicrobial chemotherapy 1999;43(6):846-8.
1999: Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group.
The Journal of antimicrobial chemotherapy 1999;43(6):783-92.
1999: P Martinez-Freijo; Ad C Fluit; Franz-Josef Schmitz; Jan Verhoef; M E Jones
Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe.
Antimicrobial agents and chemotherapy 1999;43(3):686-9.
1999: Franz-Josef Schmitz; Ad C Fluit; M Gondolf; R Beyrau; E Lindenlauf; Jan Verhoef; Hans-Peter Heinz; ME Jones
The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.
The Journal of antimicrobial chemotherapy 1999;43(2):253-9.
1999: M E Jones; M R Visser; M Klootwijk; P Heisig; Jan Verhoef; Franz-Josef Schmitz
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
Antimicrobial agents and chemotherapy 1999;43(2):421-3.
1999: Ad C Fluit; Franz-Josef Schmitz; ME Jones; J Acar; R Gupta; Jan Verhoef
Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. SENTRY Participants Group.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 1999;3(3):153-6.
1998: Franz-Josef Schmitz; Ad C Fluit; M Lückefahr; B Engler; B Hofmann; Jan Verhoef; Hans-Peter Heinz; Ulrich Hadding; ME Jones
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1998;42(6):807-10.
1998: P Martinez-Freijo; Ad C Fluit; Franz-Josef Schmitz; V S Grek; Jan Verhoef; M E Jones
Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds.
The Journal of antimicrobial chemotherapy 1998;42(6):689-96.
1998: Franz-Josef Schmitz; B Hertel; B Hofmann; Sybille Scheuring; Jan Verhoef; Ad C Fluit; Hans-Peter Heinz; Karl Köhrer; M E Jones
Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains.
The Journal of antimicrobial chemotherapy 1998;42(4):561-3.
1998: Franz-Josef Schmitz; E Lindenlauf; B Hofmann; Ad C Fluit; Jan Verhoef; Hans-Peter Heinz; ME Jones
The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals.
The Journal of antimicrobial chemotherapy 1998;42(4):489-95.
1998: Franz-Josef Schmitz; Jan Verhoef; Ulrich Hadding; Hans-Peter Heinz; ME Jones
Reduction in cytokine release from human monocytes by modifications in cell wall structure of Staphylococcus aureus induced by subinhibitory concentrations of oxacillin.
Journal of medical microbiology 1998;47(6):533-41.
1998: Franz-Josef Schmitz; ME Jones; B Hofmann; B Hansen; Sybille Scheuring; M Lückefahr; Ad C Fluit; Jan Verhoef; Ulrich Hadding; Hans-Peter Heinz; Karl Köhrer
Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.
Antimicrobial agents and chemotherapy 1998;42(5):1249-52.
1998: Franz-Josef Schmitz; Matthias Steiert; B Hofmann; Ad C Fluit; Jan Verhoef; Hans-Peter Heinz; ME Jones
Detection of staphylococcal genes directly from cerebrospinal and peritoneal fluid samples using a multiplex polymerase chain reaction.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(4):272-4.
1998: Franz-Josef Schmitz; B Hofmann; B Hansen; Sybille Scheuring; M Lückefahr; M Klootwijk; Jan Verhoef; Ad C Fluit; Hans-Peter Heinz; Karl Köhrer; ME Jones
Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1998;41(4):481-4.
1998: Franz-Josef Schmitz; Matthias Steiert; HV Tichy; B Hofmann; Jan Verhoef; Hans-Peter Heinz; Karl Köhrer; ME Jones
Typing of methicillin-resistant Staphylococcus aureus isolates from Düsseldorf by six genotypic methods.
Journal of medical microbiology 1998;47(4):341-51.
1998: Franz-Josef Schmitz; Matthias Steiert; B Hofmann; Jan Verhoef; Ulrich Hadding; Hans-Peter Heinz; Karl Köhrer
Development of a multiplex-PCR for direct detection of the genes for enterotoxin B and C, and toxic shock syndrome toxin-1 in Staphylococcus aureus isolates.
Journal of medical microbiology 1998;47(4):335-40.
1998: Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit; Hans-Peter Heinz; M E Jones
Stability of the MICs of various antibiotics in different clonal populations of methicillin-resistant Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1998;41(2):311-3.
1997: Franz-Josef Schmitz; Karin Ellen Veldkamp; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
Delta-toxin from Staphylococcus aureus as a costimulator of human neutrophil oxidative burst.
The Journal of infectious diseases 1997;176(6):1531-7.
1997: Franz-Josef Schmitz; Colin R Mackenzie; R Geisel; S Wagner; Helga Idel; Jan Verhoef; Ulrich Hadding; Hans-Peter Heinz
Methicillin resistant Staphylococcus aureus strains in the greater Düsseldorf area.
European journal of epidemiology 1997;13(6):709-17.
1997: Franz-Josef Schmitz; Colin R Mackenzie; R Geisel; S Wagner; Helga Idel; Jan Verhoef; Ulrich Hadding; Hans-Peter Heinz
Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains.
European journal of epidemiology 1997;13(6):699-708.
1997: Franz-Josef Schmitz; Colin R Mackenzie; B Hofmann; Jan Verhoef; M Finken-Eigen; Hans-Peter Heinz; Karl Köhrer
Specific information concerning taxonomy, pathogenicity and methicillin resistance of staphylococci obtained by a multiplex PCR.
Journal of medical microbiology 1997;46(9):773-8.
1997: Franz-Josef Schmitz; B Jäger; HV Tichy; Helga Idel; Ulrich Hadding; Hans-Peter Heinz
[Insertion possibility of 16S-23S space amplification and random amplified polymorphic DNA analysis for typing of methicillin-resistant Staphylococcus aureus strains in the context of nosocomial infections].
Zentralblatt für Hygiene und Umweltmedizin = International journal of hygiene and environmental medicine 1997;200(2-3):172-88.
1997: Franz-Josef Schmitz; ME Jones
Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices?
International journal of antimicrobial agents 1997;9(1):1-19.
1996: A Ring; Rodger Novak; Franz-Josef Schmitz; Hans-Peter Heinz
[Classical and current aspects of purulent meningitis].
Der Nervenarzt 1996;67(8):630-8.
1996: Franz-Josef Schmitz; R Geisel; S Wagner; W Lenz; V Kamla; Hans-Peter Heinz; Helga Idel; Ulrich Hadding
[Typing, resistance behavior and occurrence of methicillin-resistant Staphylococcus aureus strains in a surgical intensive care unit].
Zentralblatt für Hygiene und Umweltmedizin = International journal of hygiene and environmental medicine 1996;198(4):355-80.